An integrated strategy for the prevention, support and treatment of prostate cancer was launched today. The plan, which was ...

OBJECTIVE: To assess the efficacy and safety of transurethral interstitial laser coagulation (ILC) in the treatment of benign prostatic hyperplasia (BPH). PATIENTS AND METHODS: From December 1993 ...

The chemistry, pharmacology, pharmacokinetics, clinical efficacy, and adverse effects of alfuzosin hydrochloride in the treatment of benign prostatic hyperplasia (BPH) are discussed. Alfuzosin is ...

The procedure's precision reduces the risk of complications, making it an optimal choice for individuals seeking treatment for BPH. “The remarkable technology empowers urologists to leverage our ...